Showing results (281-290 of 357) with videos related to
Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993
Immunomodulatory effects of recombinant interleukin-3 treatment on human alveolar macrophages and monocytesM J Thomassen, J M Antal, M J Connors, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group StudyG T Budd, T R Fleming, R M Bukowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanomaGheath Alatrash, Thomas E Hutson, Luis Molto, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 22, 2001
Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinomaR J Motzer, A Rakhit, J A Thompson, et al.The Biochemical Journal|December 8, 1998
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalphaM Aoyama, D R Grabowski, G R Dubyak, et al.Nucleic Acids Research|December 2, 2008
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activityAdrian G Grozav, Kenichi Chikamori, Toshiyuki Kozuki, et al.Cancer|October 31, 2002
Telomerase activity in stage II colorectal carcinomaRika Kawanishi-Tabata, Francisco Lopez, Sam Fratantonio, et al.Blood|October 9, 1998
Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cellsM Aoyama, D R Grabowski, R J Isaacs, et al.International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective studySteven B Cannady, Kelly A Cavanaugh, Shih-Yuan Lee, et al.Pageof 36